Zacks.com on MSN1h
Lyell Immunopharma (LYEL) Upgraded to Buy: Here's What You Should Know
Lyell Immunopharma (LYEL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...
Zacks.com on MSN3h
INPLAY OIL CP (IPOOF) Reports Break-Even Earnings for Q3
INPLAY OIL CP (IPOOF) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.06 per share a year ago. These figures are adjusted ...
New Strong Buy Stocks for November 14th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Vanda Pharmaceuticals Inc. VNDA: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year ...
Target, BJ placed on Negative Tactical list at Evercore
Evercore ISI analysts on Thursday issued a negative tactical trading call on shares of Target Corporation (NYSE: TGT) and BJ's Wholesale Club Holdings (NYSE: BJ).
CocaCola Company (The) (KO) is Attracting Investor Attention: Here is What You Should Know
Coca-Cola (KO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.